Goodwin advised Miro in its acquisition of Freehand. Miro has acquired the visual collaboration platform, Freehand, from InVision. The deal includes the technology and brand assets, customer...
Miro’s Acquisition of Freehand
Relay’s $10 Million Seed Funding Round
Goodwin assisted Relay on the round. Relay announced its recent $10 million Series Seed financing round led by Project A Ventures and Prologis Ventures. Founded in 2022...
GoMetro’s £9 Million Series A Financing Round
Goodwin advised GoMetro on the financing. GoMetro, a South African tech company that operates in the fleet management space, has raised £9 million in a Series...
Sonic Healthcare’s $150 Million Acquisition of Pathology Watch
Goodwin advised Pathology Watch on the sale to Sonic Healthcare. Sonic Healthcare acquired Utah-based medical-tech provider Pathology Watch for US$150 million in what the Australian company...
York Capital Management’s Partnership with Comprehensive Rehab Consultants
Goodwin Procter advised York Capital Management in its strategic growth investment in Comprehensive Rehab Consultants. William Blair acted as the sell-side investment banking advisor to CRC....
Palo Alto Network’s Acquisition of Talon Cyber Security
Goodwin Procter acted as US counsel to Talon Cyber Security in the definitive agreement to be acquired by Palo Alto Network. Palo Alto Networks has acquired...
UpHealth, Inc.’s Chapter 11 Bankruptcy
Goodwin has been selected as counsel to the Official Committee of Unsecured Creditors. DLA Piper is serving as legal counsel to UpHealth. UpHealth, Inc. (NYSE: UPH), a...
LENZ Therapeutics’ Merger with Graphite Bio
Wilson Sonsini Goodrich & Rosati is representing LENZ Therapeutics in the transaction, Goodwin Procter is representing Graphite Bio and Latham & Watkins is representing the placements...
Biotheus’ Partnership with BioNTech
Goodwin Procter advised Biotheus Inc. on the agreement with BioNTech. Biotheus Inc. announced an exclusive global license and collaboration agreement with BioNTech. BioNTech will be developing, manufacturing...
Amphastar Pharmaceuticals’ $345 Million Convertible Senior Notes Offering
Goodwin advised the initial purchasers on Amphastar Pharmaceuticals, Inc.’s offering. Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the Rule 144A offering of 2.00% Convertible Senior Notes due...
TowerBrook’s Acquisition of Majority Stake in Team Eiffel
Loyens & Loeff N.V. and Goodwin advised TowerBrook Capital Partners on the acquisition of Team EIFFEL B.V.. TowerBrook Capital Partners has acquired a majority stake in Team...
Intrum’s Acquisition of Ophelos
Goodwin Procter advised Ophelos on its sale to Intrum. Through the sale, Ophelos will be able to scale and accelerate their AI products by tapping into...